COMPANY PROFILE

Sample6

Explore full profile

Synthetic, biology-based bacteria diagnostic system that is capable of enrichment-free detection

Boston, United StatesFounded 2009Biotech & Life Sciences

Valuation $50–100M Last recorded · 2016

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Sample6

Sample6 is a biotechnology company specializing in pathogen detection systems for laboratories. The company operates in the healthcare and food safety markets, providing solutions that streamline the detection of harmful pathogens. Sample6's core product, the DETECT HT system, features intuitive software and a scalable design, allowing laboratories to process up to 1,000 samples in just three hours. The system is designed for ease of use, with a single transfer sponge bag to assay plate option that simplifies operations. Sample6 serves laboratories that require efficient and reliable pathogen detection, including those in the healthcare, food safety, and environmental sectors. The business model is based on selling its detection systems and related consumables, generating revenue through both initial sales and recurring purchases of assay kits. The company aims to maximize laboratory efficiency while minimizing resource usage, making it a cost-effective solution for its clients.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2009
Headquarters: Boston, United States
Open positions: None listed
Dealroom signal: 61.4/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Testing, Risk Management, Biotechnology, Health Diagnostics, Synthetic Biology, Spinout, medical testing, DT and LS, science-based
Technology: Deep Tech
Business model: Manufacturing
Client focus: b2b
Links: Website X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

6 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES C✓Equity / VC	Aug 2016	$13M	$51M	Canaan · Acre Venture Partners · Valley Oak Investments · Cultivian Sandbox Ventures	—
SERIES B✓Equity / VC	Nov 2014	$2.5M	$10M	Undisclosed	—

Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

Sample6 website traffic

Latest recorded traffic for Sample6 is 150 monthly website visits.

Latest monthly visits150

Monthly website visitsApr 2016–Apr 2022

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
CACareDxInnovative noninvasive testing solutions enhancing transplant patient outcomes throughout their journey	Brisbane, United States	Operational	56	$79M	$2.2B
MImiDiagnosticsSilicon chip diagnostics for rapid, lab-quality results	Leuven, Belgium	Operational
PIPicturaBioBuilding instant pathogen tests using super-resolution microscopy and machine learning	Oxford, United Kingdom	Operational
LLLeuko LabsDeveloping the first device for non-invasive white cell monitoring	Boston, United States	Operational
ODOsler DiagnosticsA ground-breaking handheld diagnostic for testing a vast range of biomarkers	Oxford, United Kingdom	Operational
MAMagnomicsMolecular diagnostic devices	Cantanhede, Portugal	Closed
KIKIYATECChanging the future of cancer care by accurately predicting patient response to therapies before treatment begins	Greenville, United States	Operational
TBT2 BiosystemsDeveloping a medical diagnostic platform that enables rapid and accurate diagnostic tests of all types on a single instrument	Lexington, United States	Operational